Status:
UNKNOWN
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
Lead Sponsor:
Javeriana University
Conditions:
Covid19
Healthcare Worker Patient Transmission
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
It will be performed a randomized, multicenter, triple-masked, placebo-controlled clinical experiment to determine the effectiveness and safety of the administration to of ivermectin at a dose of 200 ...
Detailed Description
Introduction: In less than four months, an outbreak of severe pneumonia, initially identified in Wuhan (China), has spread to more than 185 countries and territories, leaving more than 1,835,000 peopl...
Eligibility Criteria
Inclusion
- Subjects over 18 years old of any sex who work as health care workers, laboriously active during the recruitment of the study in health services that do not screen for the exclusion of acutely ill patients.
- Subjects who have not presented general symptoms such as general discomfort, fever, cough, dyspnoea or muscle pain in the last week.
- Subjects with negative COVID-19 serological antibody diagnostic tests.
Exclusion
- Subjects considered as a resolved case of COVID-19 infection, according to guidelines from the Colombian National Institute of Health.
- Health personnel with social distancing due to close contact without personal protective equipment with confirmed patients of infection, or who are taking any medication as possible prophylaxis for COVID-19 (example; chloroquine, hydroxychloroquine, azithromycin)
- Health workers who have permits or temporary withdrawal from their hospital work for more than one week during the first month of the study.
- Subjects with known allergy to ivermectin.
- Women in a state of pregnancy or lactation.
- \|Subjects with a body mass index less than 18.5 and greater than 35.
Key Trial Info
Start Date :
September 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 16 2020
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT04527211
Start Date
September 7 2020
End Date
December 16 2020
Last Update
August 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pontificia Universidad Javeriana
Cali, Valle del Cauca Department, Colombia, 760501